XML 82 R50.htm IDEA: XBRL DOCUMENT
v3.25.1

Commitments and Contingent Liabilities - FronThera Contingent Consideration (Details) - FronThera - USD ($) $ in Millions | 1 Months Ended | 12 Months Ended |  |
--- | --- | --- | --- | ---
Aug. 31, 2024 | Dec. 31, 2022 | Dec. 31, 2024 | Mar. 31, 2021
FronThera Contingent Consideration |  |  |  |
Milestone payment obligation |  |  | $ 0.0 |
Clinical milestones |  |  |  |
FronThera Contingent Consideration |  |  |  |
Contingent consideration liability |  |  |  | $ 120.0
Milestone payment made | $ 23.0 | $ 37.0 |  |
Milestone payment obligation |  |  |  | 70.0
Approval milestones | Maximum |  |  |  |
FronThera Contingent Consideration |  |  |  |
Milestone payment obligation |  |  |  | $ 50.0

X
- Definition Amount of milestone obligation in connection with asset acquisition. + References No definition available. + Details
Name: | alms_AssetAcquisitionMilestoneObligation
Namespace Prefix: | alms_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Amount of milestone payment made in connection with asset acquisition. + References No definition available. + Details
Name: | alms_AssetAcquisitionPaymentOfMilestone
Namespace Prefix: | alms_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount of liability recognized from contingent consideration in asset acquisition. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 805 -SubTopic 50 -Name Accounting Standards Codification -Section 15 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480123/805-50-15-3 + Details
Name: | us-gaap_AssetAcquisitionContingentConsiderationLiability
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 805 -SubTopic 50 -Name Accounting Standards Codification -Section 15 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480123/805-50-15-3 + Details
Name: | us-gaap_AssetAcquisitionContingentConsiderationLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_AssetAcquisitionAxis=alms_FrontheraUsHoldingsIncAndFrontheraUsPharmaceuticalsLlcMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ContingentConsiderationByTypeAxis=alms_ClinicalMilestonesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ContingentConsiderationByTypeAxis=alms_ApprovalMilestonesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MaximumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |